Published in PLoS Med on January 17, 2006
Acute lower respiratory tract infection. N Engl J Med (2008) 3.70
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev (2010) 3.31
CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity (2010) 2.16
The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05
Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immun (2008) 1.87
Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med (2009) 1.74
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol (2009) 1.71
Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults. J Infect Dis (2015) 1.63
The role of the bacterial microbiome in lung disease. Expert Rev Respir Med (2013) 1.62
Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am J Respir Cell Mol Biol (2008) 1.49
Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol (2009) 1.48
Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung. PLoS Pathog (2015) 1.48
Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia. J Immunol (2007) 1.43
Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med (2014) 1.36
CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. J Immunol (2010) 1.30
STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol (2012) 1.29
Mechanisms of neutrophil accumulation in the lungs against bacteria. Am J Respir Cell Mol Biol (2009) 1.28
A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog (2011) 1.22
NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection. J Immunol (2012) 1.22
The impact of successive infections on the lung microenvironment. Immunology (2007) 1.21
Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J Immunol (2011) 1.16
Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun (2011) 1.16
Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice. J Clin Invest (2012) 1.16
Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. J Immunol (2012) 1.14
Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res (2008) 1.10
Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells. J Biol Chem (2012) 1.10
Cell elasticity determines macrophage function. PLoS One (2012) 1.05
Respiratory infection and the impact of pulmonary immunity on lung health and disease. Am J Respir Crit Care Med (2012) 1.04
Myeloid differentiation protein-2-dependent and -independent neutrophil accumulation during Escherichia coli pneumonia. Am J Respir Cell Mol Biol (2008) 1.02
Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front Cell Infect Microbiol (2013) 1.01
Virally delivered cytokines alter the immune response to future lung infections. J Virol (2007) 1.01
Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS One (2012) 1.00
Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun (2010) 1.00
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol (2014) 1.00
Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect Immun (2009) 1.00
Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia. Am J Respir Cell Mol Biol (2011) 0.98
The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation. Cell Host Microbe (2014) 0.98
One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis (2011) 0.97
The role of toll-like receptors in acute and chronic lung inflammation. J Inflamm (Lond) (2010) 0.97
Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. J Immunol (2012) 0.94
Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis. Infect Immun (2009) 0.94
Viral etiologies of hospitalized acute lower respiratory infection patients in China, 2009-2013. PLoS One (2014) 0.93
Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A. Infect Immun (2011) 0.92
Review: Toll-like receptors and NOD-like receptors in pulmonary antibacterial immunity. Innate Immun (2010) 0.92
Extracellular superoxide dismutase in macrophages augments bacterial killing by promoting phagocytosis. Am J Pathol (2011) 0.92
Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob Agents Chemother (2015) 0.91
Lung epithelial cells are essential effectors of inducible resistance to pneumonia. Mucosal Immunol (2013) 0.91
Severe viral respiratory infections: are bugs bugging? Mucosal Immunol (2013) 0.90
Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. Annu Rev Physiol (2014) 0.89
Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization. Infect Immun (2013) 0.89
Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections. Exp Gerontol (2009) 0.89
Priorities for respiratory research in the UK. Thorax (2007) 0.89
Leukemia inhibitory factor signaling is required for lung protection during pneumonia. J Immunol (2012) 0.88
Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2. J Leukoc Biol (2012) 0.88
Retracted NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection. Infect Immun (2012) 0.87
Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study. BMC Pulm Med (2012) 0.87
IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense. Mucosal Immunol (2015) 0.86
Vitamin C may affect lung infections. J R Soc Med (2007) 0.86
Genomic analysis of 16 Colorado human NL63 coronaviruses identifies a new genotype, high sequence diversity in the N-terminal domain of the spike gene and evidence of recombination. J Gen Virol (2012) 0.86
Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. Crit Care (2010) 0.86
Respiratory virus infections in hospitalized children and adults in Lao PDR. Influenza Other Respir Viruses (2013) 0.85
Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression. J Immunol (2008) 0.85
Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J (2015) 0.85
Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection. Antimicrob Agents Chemother (2013) 0.84
Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia. PLoS One (2013) 0.83
Retracted Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway. Infect Immun (2013) 0.83
Roles of STAT3 in protein secretion pathways during the acute-phase response. Infect Immun (2013) 0.83
Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation model. Mol Med (2011) 0.82
OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses. Immunol Rev (2011) 0.82
Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target. Elife (2014) 0.82
The Lung-Liver Axis: A Requirement for Maximal Innate Immunity and Hepatoprotection during Pneumonia. Am J Respir Cell Mol Biol (2015) 0.81
Epidemiology of human respiratory viruses in children with acute respiratory tract infections in Jinan, China. Clin Dev Immunol (2013) 0.81
Gut flora enhance bacterial clearance in lung through toll-like receptors 4. J Biomed Sci (2011) 0.80
Induction of STAT3-Dependent CXCL5 Expression and Neutrophil Recruitment by Oncostatin-M during Pneumonia. Am J Respir Cell Mol Biol (2015) 0.80
Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. Am J Physiol Lung Cell Mol Physiol (2015) 0.79
Intraalveolar Catecholamines and the Human Lung Microbiome. Am J Respir Crit Care Med (2015) 0.79
Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection. J Immunol (2015) 0.79
Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection. PLoS One (2014) 0.79
With Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia. Front Cell Infect Microbiol (2017) 0.78
Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers. Prostaglandins Other Lipid Mediat (2013) 0.78
NLRP12 modulates host defense through IL-17A-CXCL1 axis. Mucosal Immunol (2015) 0.78
Ablation of leptin receptor-mediated ERK activation impairs host defense against Gram-negative pneumonia. J Immunol (2012) 0.78
Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2. Respir Res (2011) 0.77
Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med (2015) 0.77
Divergent functions of Toll-like receptors during bacterial lung infections. Am J Respir Crit Care Med (2014) 0.77
Gene expression analysis of TREM1 and GRK2 in polymorphonuclear leukocytes as the surrogate biomarkers of acute bacterial infections. Int J Med Sci (2014) 0.77
Gastroesophageal Reflux Burden, Even in Children That Aspirate, Does Not Increase Pediatric Hospitalization. J Pediatr Gastroenterol Nutr (2016) 0.77
Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis. Sci Rep (2015) 0.76
β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study. BMC Med Genet (2015) 0.76
Inducible epithelial resistance protects mice against leukemia-associated pneumonia. Blood (2016) 0.76
Inflammatory Responses Regulating Alveolar Ion Transport during Pulmonary Infections. Front Immunol (2017) 0.75
Respiratory viral infections and host responses; insights from genomics. Respir Res (2016) 0.75
Corticosteroids for community-acquired pneumonia: time to act! Crit Care (2008) 0.75
Effects of health intervention programs and arsenic exposure on child mortality from acute lower respiratory infections in rural Bangladesh. Int J Health Geogr (2016) 0.75
Humanized Mouse Models of Staphylococcus aureus Infection. Front Immunol (2017) 0.75
Cost-effectiveness analysis of oral versus intravenous drip infusion of levofloxacin in the treatment of acute lower respiratory tract infection in Chinese elderly patients. Clin Interv Aging (2017) 0.75
THP-1-derived macrophages render lung epithelial cells hypo-responsive to Legionella pneumophila - a systems biology study. Sci Rep (2017) 0.75
Incidence of Respiratory Disease During the First Two Years of Life in Children with Hemodynamically Significant Congenital Heart Disease in Italy: A Retrospective Study. Pediatr Cardiol (2016) 0.75
Myeloid-epithelial crosstalk coordinates synthesis of the tissue protective cytokine leukemia inhibitory factor during pneumonia. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Trends in infectious disease mortality in the United States during the 20th century. JAMA (1999) 4.97
Burden of disease--implications for future research. JAMA (2001) 4.75
Preparing for the next pandemic. N Engl J Med (2005) 4.65
Improving the health of the global poor. Science (2002) 3.69
Effective antibiotic-resistance control strategies. Lancet (2001) 3.04
Pneumonia in the very old. Lancet Infect Dis (2004) 2.19
Avian influenza remains a cause for concern. Lancet (2005) 1.05
Public health. Pandemic or not, experts welcome Bush flu plan. Science (2005) 1.04